Phenylbutenamine

Pharmaceutical compound From Wikipedia, the free encyclopedia

Phenylbutenamine, or 4-phenylbut-3-en-2-amine, is a monoamine releasing agent (MRA) of the arylalkylamine family related to β-phenethylamine and amphetamine.[1][2] It has two possible stereoisomers: (3E)-phenylbutenamine (PAL-881) and (3Z)-phenylbutenamine (PAL-893).[1][2] Both of these enantiomers act as norepinephrine–dopamine releasing agents (NDRAs), and to similar comparative extents, albeit with far lower potency than β-phenethylamine or amphetamine.[1][2][3]

Other names4-Phenylbut-3-en-2-amine; 1-Methyl-3-phenylprop-2-enylamine; PAL-881/PAL-893
PubChem CID
Quick facts Clinical data, Other names ...
Phenylbutenamine
Clinical data
Other names4-Phenylbut-3-en-2-amine; 1-Methyl-3-phenylprop-2-enylamine; PAL-881/PAL-893
Drug classNorepinephrine–dopamine releasing agent[1][2]
Identifiers
  • 4-phenylbut-3-en-2-amine
PubChem CID
ChemSpider
Chemical and physical data
FormulaC10H13N
Molar mass147.221 g·mol−1
3D model (JSmol)
  • CC(C=CC1=CC=CC=C1)N
  • InChI=1S/C10H13N/c1-9(11)7-8-10-5-3-2-4-6-10/h2-9H,11H2,1H3
  • Key:QPVUUOXSCVQZQG-UHFFFAOYSA-N
Close

See also

References

Related Articles

Wikiwand AI